Trial Profile
A prospective, observational study assessing the correlation between vedolizumab trough levels and the treatment response in patients with inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Pharmacokinetics; Therapeutic Use
- 06 Dec 2018 New trial record